View in EDS PDF Full Text

Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.

Saved in:
Bibliographic Details
Title: Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.
Authors: Hashimoto, Teppei1 (AUTHOR) te-hashimoto@hyo-med.ac.jp, Yoshida, Kohsuke2 (AUTHOR), Yokoyama, Yuichi3 (AUTHOR), Hashimoto, Naonori4 (AUTHOR), Kaneshiro, Kenta4 (AUTHOR), Yoshikawa, Takahiro1 (AUTHOR), Tateishi, Koji5 (AUTHOR), Terashima, Yasuhiro5 (AUTHOR), Matsui, Kiyoshi1 (AUTHOR), Hashiramoto, Akira4 (AUTHOR)
Source: Clinical & Experimental Immunology. Aug2023, Vol. 213 Issue 2, p209-220. 12p. 1 Diagram, 2 Charts, 5 Graphs.
Database: Academic Search Ultimate
Description
ISSN:00099104
DOI:10.1093/cei/uxad064